Endoscopic Mucosal Resection

EMR is used to remove certain lesions confined to the inner layers of the gastrointestinal tract, especially in the esophagus, stomach, duodenum, and colon. These may include selected polyps, dysplastic tissue, early-stage neoplastic lesions, or suspicious superficial abnormalities. One of the major advantages of EMR is that it can provide a less invasive, organ-preserving alternative to surgery in carefully chosen cases. ^[1][2][3][4]

However, not every lesion is suitable for this approach. The size, shape, location, endoscopic appearance, lifting characteristics, and suspicion for deeper invasion all influence the decision. Some lesions are better treated with standard polypectomy, some with endoscopic submucosal dissection, and some with surgery instead. The key question is whether the lesion appears superficial enough to allow safe and meaningful endoscopic removal. ^[1][4][6][7]

Before EMR, the lesion is usually evaluated carefully with endoscopy and sometimes with enhanced imaging, dye-based techniques, or endoscopic ultrasound depending on the location and concern. Medications, especially blood thinners, must also be reviewed. The physician’s aim is not only to remove tissue, but to determine whether the lesion can be removed in a way that is technically safe and pathologically informative. ^[1][3][4][6]

During the procedure, fluid is often injected beneath the lesion to lift it away from deeper layers. A snare is then used to remove it. In some cases, cap-assisted, band-assisted, or underwater techniques may be used depending on the anatomy and lesion type. The procedure is performed under sedation, so most patients do not experience significant pain, although they may feel temporary bloating or mild discomfort afterward. ^[1][3][4][5]

A major strength of EMR is that it yields tissue for pathology. This can help distinguish superficial dysplasia from invasive cancer and clarify whether the lesion has been removed completely. If pathology shows clear margins, no deep invasion, and no additional high-risk features, EMR may be sufficient treatment in selected patients. If lymphovascular invasion, deeper submucosal spread, or poor differentiation is found, more treatment may still be required. That is why the pathology report—not just the technical completion of the procedure—is central to decision-making. ^[1][4][7]

EMR is generally considered safe, but it is not risk-free. Potential complications include bleeding, perforation, post-procedural pain, stricture formation in certain locations, and residual or recurrent lesion tissue. Bleeding can often be treated endoscopically during the procedure, but delayed bleeding may also occur. In esophageal lesions, stricture risk can become relevant if a large area is removed; in the colon, delayed bleeding and surveillance for recurrence are especially important. ^[1][2][4][6]

Recovery depends on the size and location of the resection. Small, limited resections may allow same-day discharge, while larger procedures may require longer observation. Patients usually receive instructions on diet progression, medication timing, blood-thinner management, and follow-up endoscopy. Surveillance is an important part of care because some patients may have residual tissue or recurrence at the resection site over time. ^[1][2][3][6]

After EMR, urgent medical assessment is needed for severe abdominal pain, fever, marked difficulty swallowing, black stools, visible bleeding, fainting, or worsening chest or abdominal pain. Such symptoms may suggest complications such as perforation or significant bleeding and should not be ignored. ^[1][2][4][5]

In summary, endoscopic mucosal resection is a valuable diagnostic and therapeutic procedure for selected superficial gastrointestinal lesions. Its success depends not only on technique, but also on careful pre-procedure assessment, pathology interpretation, and structured follow-up. ^[1][2][4][5]